Frecuencia cardiaca en reposo y enfermedad cardiovascular

作者: Buenaventura Brito Díaz , José Juan Alemán Sánchez , Antonio Cabrera de León

DOI: 10.1016/J.MEDCLI.2013.05.034

关键词:

摘要: Heart rate reflects autonomic nervous system activity. Numerous studies have demonstrated that an increased heart at rest is associated with cardiovascular morbidity and mortality as independent risk factor. It has been shown a link between cardiac balance inflammation. Thus, elevated produces micro-inflammatory response involved in the pathogenesis of endothelial dysfunction. In turn, decrease benefits congestive failure, myocardial infarction, atrial fibrillation, obesity, hyperinsulinemia, insulin resistance, atherosclerosis. Alteration other rate-related parameters, such their variability recovery after exercise, events. Drugs reducing (beta-blockers, calcium antagonists inhibitors If channels) potential to reduce Although not recommended healthy subjects, interventions for constitute reasonable therapeutic goal certain pathologies.

参考文章(44)
A S Hall, S Palmer, The heart rate hypothesis: ready to be tested Heart. ,vol. 94, pp. 561- 565 ,(2008) , 10.1136/HRT.2007.118760
Valerio Zacà, Livio Dei Cas, Silvia Bugatti, Carlo Lombardi, Marco Metra, La frequenza cardiaca: fattore di rischio o epifenomeno? Giornale italiano di cardiologia. ,vol. 11, pp. 209- 220 ,(2010)
Florian Custodis, Stephan H. Schirmer, Magnus Baumhäkel, Gerd Heusch, Michael Böhm, Ulrich Laufs, Vascular Pathophysiology in Response to Increased Heart Rate Journal of the American College of Cardiology. ,vol. 56, pp. 1973- 1983 ,(2010) , 10.1016/J.JACC.2010.09.014
George D. Giannoglou, Yiannis S. Chatzizisis, Chrysanthos Zamboulis, George E. Parcharidis, Dimitri P. Mikhailidis, George E. Louridas, Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms International Journal of Cardiology. ,vol. 126, pp. 302- 312 ,(2008) , 10.1016/J.IJCARD.2007.08.077
José Mora-Maciá, Aleix Cases, Munther Alami, Irene Agraz, Pere Barceló, Josep Esqué, Análisis de la frecuencia cardíaca como factor de riesgo asociado a la progresión de la insuficiencia renal crónica Medicina Clinica. ,vol. 119, pp. 245- 248 ,(2002) , 10.1016/S0025-7753(02)73376-9
Tavazzi L Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, SHIFT Investigators., None, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. ,vol. 376, pp. 875- 885 ,(2010) , 10.1016/S0140-6736(10)61198-1
O Rogowski, I Shapira, A Shirom, S Melamed, S Toker, S Berliner, Heart rate and microinflammation in men: a relevant atherothrombotic link Heart. ,vol. 93, pp. 940- 944 ,(2007) , 10.1136/HRT.2006.101949
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs, Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice Circulation. ,vol. 117, pp. 2377- 2387 ,(2008) , 10.1161/CIRCULATIONAHA.107.746537
Graziano Riccioni, Focus on ivabradine: a new heart rate-controlling drug. Expert Review of Cardiovascular Therapy. ,vol. 7, pp. 107- 113 ,(2009) , 10.1586/14779072.7.2.107